Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Employee Benefit Plans (Tables)

v3.8.0.1
Stock-Based Compensation and Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
The Company recognizes stock-based compensation in the consolidated statements of income, based on the department to which the related employee reports, as follows:
 
Three Months Ended March 31,
 
2018
 
2017
 
(in thousands)
Cost of net revenue
$
106

 
$
59

Research and development
4,374

 
3,493

Selling, general and administrative
3,993

 
1,922

 
$
8,473

 
$
5,474

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
 
Number of Shares
(in thousands)
 
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2017
3,183

 
$
20.13

Granted
397

 
23.42

Vested
(663
)
 
19.97

Canceled
(58
)
 
22.36

Outstanding at March 31, 2018
2,859

 
20.61

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
 
Three Months Ended
 
March 31, 2018
Weighted-average grant date fair value per share
$
6.51

Risk-free interest rate
1.39
%
Dividend yield
%
Expected life (in years)
0.50

Volatility
36.97
%
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of the Company’s stock options activity is as follows:
 
Number of Options
(in thousands)
 
Weighted-Average Exercise Price
 
Weighted-Average Contractual Term (in years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2017
3,069

 
$
8.95

 
 
 
 
Exercised
(129
)
 
7.63

 
 
 
 
Canceled
(5
)
 
18.40

 
 
 
 
Outstanding at March 31, 2018
2,935

 
$
8.99

 
2.36
 
$
40,641

Vested and expected to vest at March 31, 2018
2,899

 
$
8.90

 
2.33
 
$
40,413

Exercisable at March 31, 2018
2,559

 
$
8.07

 
2.03
 
$
37,767